a16z Perennial Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
RG
CDDEC
BTCPP
AAMU
ISS
AIM
a16z Perennial Management's AZN Position: Q2 2026 in Review
a16z Perennial Management sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 1,993 shares — an estimated $393K sold.
a16z Perennial Management first reported a position in AZN in Q3 2025 and held it in 3 quarters. The position peaked at $393K in Q1 2026. 655 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- a16z Perennial Management reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
- a16z Perennial Management sold 1,993 AstraZeneca shares in Q2 2026, an estimated $393K.
- a16z Perennial Management first reported a position in AstraZeneca in Q3 2025 and held it in 3 quarters.
- a16z Perennial Management's AstraZeneca position peaked at $393K in Q1 2026.
- 655 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on a16z Perennial Management's 13F filing for Q2 2026, filed 24 Jul 2026.